Remove Digital Media Remove Healthcare Remove Leads Remove Pharma
article thumbnail

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising. Given their often niche content, pharma marketers must target smaller, more exclusive audiences to drive results while developing impactful creative.

Pharma 98
article thumbnail

2022 Predictions From the Front-Lines of Pharma Digital Advertising

Pharma Marketing Network

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. A Continued Boost in Pharma’s Reputation.

Pharma 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meeting MSL training needs in an evolving landscape

pharmaphorum

Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. But who keeps the MSLs up-to-date, and who makes sure they have the hard and soft skills necessary to be an effective partner for healthcare professionals?

article thumbnail

Cutting Through the Digital Clutter with Data-Driven Marketing

PM360

While pharma brands have learned many valuable lessons during the COVID-19 pandemic, some painful realities of digital marketing still remain. On average, pharmaceutical companies have increased their overall digital media spend more than 50% compared to pre-COVID-19 levels. We have created our own clutter.

article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member. So tell me about the latest happenings that you’re seeing in the world of healthcare and digital innovation.

Pharma 52
article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member. So tell me about the latest happenings that you’re seeing in the world of healthcare and digital innovation.

Pharma 40
article thumbnail

The future of the UK pharma market: A global context

pharmaphorum

This study indicates that in the wider global context, the UK still matters for launch as one of the lead developed markets which account for the overwhelming majority of the early years of new chemical entity sales. Companies which address these issues will be those that can optimize the uptake of innovative products in the UK market.